Table 1.
All participants | % | Late diagnosis n=87 | % | Early diagnosis n=84 | % | Χ2-value (P-value) | |
---|---|---|---|---|---|---|---|
Gender: n=171 | 1.70 (0.19) | ||||||
Male | 116 | 67.8 | 63 | 72.4 | 53 | 63.1 | |
Female | 55 | 32.2 | 24 | 27.6 | 31 | 36.9 | |
Age: n=171 | 5.19 (0.07) | ||||||
18–30 yrs | 52 | 30.4 | 20 | 23.0 | 32 | 38.1 | |
31–50 yrs | 91 | 53.2 | 53 | 60.9 | 38 | 45.2 | |
>50 yrs | 28 | 16.4 | 14 | 16.1 | 14 | 16.7 | |
Race: n=171 | 5.66 (0.06) | ||||||
Hispanic | 68 | 39.8 | 42 | 48.3 | 26 | 31.0 | |
Black | 87 | 50.9 | 37 | 42.5 | 50 | 59.5 | |
White | 16 | 9.4 | 8 | 9.2 | 8 | 9.5 | |
Education: n=169 | 5.66 (0.06) | ||||||
No degree | 76 | 45.0 | 44 | 51.2 | 32 | 38.6 | |
High school/GED | 44 | 26.0 | 24 | 27.9 | 20 | 24.1 | |
Any college | 49 | 29.0 | 18 | 20.9 | 31 | 37.3 | |
Annual income: n=167 | 0.49 (0.78) | ||||||
<$14,999 | 108 | 64.7 | 53 | 62.4 | 55 | 67.1 | |
$15,000–$24,999 | 36 | 21.6 | 19 | 22.4 | 17 | 20.7 | |
>$25,000 | 23 | 13.8 | 13 | 15.3 | 10 | 12.2 | |
HIV risk: n=170 | 2.36 (0.12) | ||||||
IDU/MSM | 67 | 39.4 | 29 | 33.7 | 38 | 45.2 | |
Other | 103 | 60.6 | 57 | 66.3 | 46 | 54.8 | |
Diagnosis: n=171 | 35.4 (<0.001) | ||||||
Hospital/ER | 76 | 44.4 | 58 | 66.7 | 18 | 21.4 | |
Other | 95 | 55.5 | 29 | 33.3 | 66 | 78.6 |
Abbreviations: GED, graduate equivalency degree; IDU, injection drug use; MSM, men who have sex with men; ER, emergency room.